PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the following investor conferences in March:
PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the following investor conferences in March: